Cargando…
Blood-CNS Barrier Impairment in ALS patients versus an animal model
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease with a complicated and poorly understood pathogenesis. Recently, alterations in the blood–Central Nervous System barrier (B-CNS-B) have been recognized as a key factor possibly aggravating motor neuron damage. The majority of...
Autores principales: | Garbuzova-Davis, Svitlana, Sanberg, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910123/ https://www.ncbi.nlm.nih.gov/pubmed/24550780 http://dx.doi.org/10.3389/fncel.2014.00021 |
Ejemplares similares
-
Blood-Brain Barrier Impairment in an Animal Model of MPS III B
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2011) -
Blood-brain barrier impairment in MPS III patients
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2013) -
Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2007) -
Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018) -
Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008)